Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes
Not Applicable
Completed
- Conditions
- Benign Prostatic Hyperplasia
- Registration Number
- NCT04566588
- Lead Sponsor
- University of Kansas Medical Center
- Brief Summary
To determine if early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia, reduces post-operative urinary incontinence compared to classic HoLEP.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
- Patients must be 18 years of age or older
- Patients must present to clinic with a diagnosis of benign prostatic hyperplasia
- Patients must be scheduled to undergo a holmium laser enucleation of the prostate
Exclusion Criteria
- Patients with previous surgical management of BPH
- Patients with prostate biopsy revealing high risk prostate cancer
- Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Post-operative Urinary Incontinence Twelve Months Post-operative to determine if patients who undergo early apical release HoLEP have reduced rates of post-operative urinary incontinence compared to classic HoLEP as measured by patient report of leakage
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Kansas Health System
🇺🇸Kansas City, Kansas, United States
University of Kansas Health System🇺🇸Kansas City, Kansas, United States